Mumbai, India, and Morristown, NJ—OmniActive Health Technologies has announced that TA Associates, a global growth private equity firm, has acquired a significant stake in the company, while OmniActive’s Founder and Executive Chairman Sanjay Mariwala has further increased his personal holding.
In a press release, Mariwala stated: “We are pleased to welcome TA Associates as a strategic investor and partner for the next phase of OmniActive’s growth journey. We believe that TA has deep capabilities and experience investing in companies focused on nutritional ingredients, and shares OmniActive’s vision of bringing innovative, natural and science-based solutions to our customers and end consumers. We intend to leverage our strong management capabilities and TA’s distinctive M&A sourcing engine to drive programmatic M&A and in-licensing to continuously deliver innovation to our customers.”
“We believe that the nutritional ingredients space will see strong growth over the next decade. OmniActive has built a strong reputation and deep customer relationships by focusing on natural, R&D-led innovative ingredients. We look forward to working together with Mr. Mariwala and the OmniActive management team to further accelerate the growth in this business through organic levers and M&A,” added Naresh Patwari, a Director at TA Associates Advisory Private Limited.
Jim Hamilton, CEO of OmniActive, said: “We believe that TA’s global healthcare experience will be valuable in supporting OmniActive’s next phase of growth through continued organic growth and strategic acquisitions. OmniActive has been growing at an accelerated pace, driven by a portfolio of branded, innovative natural products with clinically supported health benefits, and we are excited to continue this growth journey and supporting our customers with TA as our new equity partner.”
Dhiraj Poddar, a Managing Director at TA Associates, concluded: “We are impressed by the quality of OmniActive’s business and customer franchise. We believe that OmniActive is well-placed to benefit from the strong growth in the nutraceuticals ingredients space, and look forward to our partnership.”